The global dementia burden is growing rapidly, while healthcare systems face increasing pressure from limited specialist capacity, long waiting times, and rising demand for earlier diagnosis.
 
Our vision is to work with pharmaceutical companies, clinical researchers, diagnostic laboratories, and healthcare providers to expand the role of DementiaDX across:

• Patient triage into AD and non-AD diagnostic and treatment pathways

• Patient identification and stratification for clinical trials in pharma

• Differential diagnosis in the clinic

• Monitoring treatment efficacy

• Population-scale screening approaches

​As new Alzheimer’s and neurodegenerative therapies emerge, there is increasing need for scalable tools capable of identifying appropriate patients earlier and more efficiently- 
 
Our goal is to help bridge the gap between scientific advances in neurodegenerative treatment and the real-world diagnostic infrastructure required to deliver them at scale with distributed accessibility.